FDA Commissioner Resigns a Month Before Scheduled CBD Hearings
Congressional hearings on the status of CBD hearings were scheduled for April 2019 to discuss the path forward for the regulatory regime surrounding hemp products under the Farm Bill. With a new major shift at the Food and Drug Administration (FDA), that plan might be delayed. FDA Commissioner Resigns from Office Scott Gottlieb has been …
FDA Commissioner Resigns a Month Before Scheduled CBD Hearings Read More »
